跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRILIGY dapoxetine 30 mg (as hydrochloride) film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PRILIGY dapoxetine 30 mg (as hydrochloride) film-coated tablet blister pack
Approved
STANDARD
PRILIGY dapoxetine 30 mg (as hydrochloride) film-coated tablet blister pack
A Menarini Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ec312f5f080adc40
Company
A Menarini Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ec312f5f080adc40
Product Name
PRILIGY dapoxetine 30 mg (as hydrochloride) film-coated tablet blister pack
Artg Id
147946
Artg Name
PRILIGY dapoxetine 30 mg (as hydrochloride) film-coated tablet blister pack
Sponsor
A Menarini Australia Pty Ltd
Artg Date
2010-09-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0b6761279bce103fbdcf0c797411c9e7.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b3104f7a5cb2e5660e9ff11365b5496b.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ec312f5f080adc40
Type
Standard
Back to TGA Approvals